Alleviant Medical Inc
Austin, US · Founded 2017 · Delaware corporation · 58 employees on LinkedIn · 10 known investors
Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).
Founders & leadership
Alleviant Medical Inc was founded in 2017 by Adam Berman.
AB
Adam BermanFounder
JK
Jacob KriegelNamed on SEC filing
AP
Avni PatelNamed on SEC filing
CA
Christopher Alex ArevalosNamed on SEC filing
AG
Albertien GreijdanusNamed on SEC filing
Board
GP
Geoff PardoBoard director
BR
Brian R SmithBoard director
MB
KN
CK
Christopher KasterBoard director
JS
Jay SchmelterinBoard directorCo-founder of RiverVest Venture Partners, funding and founding life science companies
IM
Investors · 10
Broadview VenturesBoston
RiverVest Venture PartnersSt. Louis · $500K – $3Mvia Jay W. Schmelter · board
TMC Venture FundHouston
Cadence Healthcare VenturesreportedHayward
Gilde HealthcarereportedUtrecht · $1.1M – $55M
Gilmartin Capital LLCreportedLarkspur
S3 VenturesreportedAustin · $500K – $15M
Vensana Capitalreported · 3 sourcesMinneapolisvia Kirk Nielsen · board
Also in the syndicate · 2
Longview VenturesOmega Funds
Reported raises · per SEC filings
Form D private placements$148.8M disclosed across 4 rounds · 2017–2024
▶$90.8MraisedJan 2025 · 12 investors · Other Health CareRule 506(b)
▶$90.8MraisedJan 2025 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Geoff PardoDirector
- Ian MeredithDirector
- Brian R SmithDirector
- Maria BerkmanDirector
- Adam BermanExecutive Officer, Director
- Kirk NielsenDirector
- Christopher KasterDirector
- Jay SchmelterDirector
- Offering amount
- $91.4M
- Amount sold
- $90.8M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$43.9MraisedFeb 2023 · 35 investors · Other Health CareRule 506(b)
▶$43.9MraisedFeb 2023 · 35 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brian R SmithDirector
- Gowda AshokDirector
- Kirk NielsonDirector
- Christopher KasterDirector
- Maria BerkmanDirector
- Jay SchmelterDirector
- Adam BermanExecutive Officer, Director
- Offering amount
- $88.3M
- Amount sold
- $43.9M
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13MraisedNov 2020 · 18 investors · Other Health CareRule 506(b)
▶$13MraisedNov 2020 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mary ByronDirector
- Ashok GowdaDirector
- Christopher KasterDirector
- Kirk NielsenDirector
- Adam BermanExecutive Officer, Director
- Jacob KriegelDirector
- Maria BerkmanDirector
- Offering amount
- $20M
- Amount sold
- $13M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1.1MraisedMar 2018 · 15 investors · BiotechnologyRule 506(b)
▶$1.1MraisedMar 2018 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jacob KriegelExecutive Officer, Director
- Avni PatelExecutive Officer, Director
- Christopher Alex ArevalosExecutive Officer, Director
- Albertien GreijdanusExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Rf Surgical10 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Veeva7 shared keywordsVeeva Clinical Platform is a cloud-based suite of connected applications for running clinical trials, covering clinical operations, clinical data, research sites, and patients. It serves biopharma sponsors, clinical research sites, and patients across trial management, data capture, and disclosures.
Companies competing with Alleviant Medical Inc for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $313.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Alleviant Medical Inc do?
- Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).
- Who founded Alleviant Medical Inc?
- Alleviant Medical Inc was founded by Adam Berman in 2017.
- Who are Alleviant Medical Inc's investors?
- Alleviant Medical Inc's investors include Broadview Ventures, RiverVest Venture Partners, TMC Venture Fund, Cadence Healthcare Ventures, Gilde Healthcare, Gilmartin Capital LLC, S3 Ventures, Vensana Capital.
- How much funding has Alleviant Medical Inc raised?
- Alleviant Medical Inc has disclosed $148.8M raised across 4 rounds.
- Where is Alleviant Medical Inc headquartered?
- Alleviant Medical Inc is headquartered in Austin, US.